BRIEF published on 06/14/2024 at 22:50, 2 years 3 months ago Reminder Notice of Annual General and Special Meeting for Shareholders of Theralase® Shareholders Theralase® Virtual Meeting AGSM Zoom Presentation
BRIEF published on 06/14/2024 at 22:50, 2 years 3 months ago Avis de rappel d'assemblée générale annuelle et extraordinaire des actionnaires de Theralase® Actionnaires Theralase® Réunion Virtuelle AGSM Présentation Zoom
PRESS RELEASE published on 06/14/2024 at 22:45, 2 years 3 months ago Reminder Notice of Annual General and Special Meeting for Shareholders of Theralase(R) Theralase Technologies Inc. provides a reminder for its Annual General and Special Meeting to be held on June 19th, 2024, with a virtual Zoom presentation including a Q&A session for shareholders Annual General Meeting Shareholders Theralase Technologies Inc. AGSM Virtual Zoom Presentation
BRIEF published on 06/12/2024 at 13:05, 2 years 3 months ago Rutherrin® Increases Efficacy of Chemotherapy Cancer Treatment Chemotherapy Rutherrin® Multidrug Resistance Theralase® Technologies
BRIEF published on 06/12/2024 at 13:05, 2 years 3 months ago Rutherrin® augmente l'efficacité de la chimiothérapie Traitement Du Cancer Chimiothérapie Rutherrin® Résistance Multidrogue Technologies Theralase®
PRESS RELEASE published on 06/12/2024 at 13:00, 2 years 3 months ago Rutherrin(R) Increases Efficacy of Chemotherapy Theralase Technologies announces preclinical success of Rutherrin® in enhancing chemotherapy efficacy and reducing multidrug resistance in cancer cells Cancer Treatment Theralase Technologies Rutherrin® Multidrug Resistance Chemotherapy Efficacy
BRIEF published on 06/10/2024 at 13:05, 2 years 3 months ago Ruvidar(TM) Enhances Efficacy of Cancer Drug Cancer Treatment Theralase Technologies Ruvidar(TM) BCG NMIBC
BRIEF published on 06/10/2024 at 13:05, 2 years 3 months ago Ruvidar(TM) améliore l'efficacité d'un médicament contre le cancer Traitement Du Cancer Technologies Théralase Ruvidar(TM) BCG NMIBC
PRESS RELEASE published on 06/10/2024 at 13:00, 2 years 3 months ago Ruvidar(TM) Enhances Efficacy of Cancer Drug Theralase® Technologies Inc. announces breakthrough in cancer research by developing RuBCG compound to enhance efficacy of bladder cancer treatment. Preclinical results show promising potential Theralase Technologies Inc. Cancer Research RuBCG Compound Bladder Cancer Treatment Preclinical Results
BRIEF published on 06/06/2024 at 13:05, 2 years 3 months ago Theralase Successfully Destroys Lung Cancer Preclinical Study Theralase Technologies Lung Cancer Rutherrin®
Published on 10/01/2026 at 08:02, 3 hours 3 minutes ago Southern Energy Announces Results of Annual Meeting and Board Changes
Published on 10/01/2026 at 01:21, 9 hours 44 minutes ago Revival Gold Announces Filing of Final Base Shelf Prospectus
Published on 10/01/2026 at 01:00, 10 hours 5 minutes ago Algo Grande Copper Secures Five-Year Surface Access Agreement With Ejido Palos Chinos at the Adelita Project
Published on 09/30/2026 at 23:30, 11 hours 35 minutes ago Early Warning News Release Issued with Respect to the Acquisition of Securities of Cypher Metaverse Inc.
Published on 09/30/2026 at 20:35, 14 hours 30 minutes ago Fairplay Ventures Inc. Enters Into Definitive Agreement to Complete Qualifying Transaction With Ampere Metals Pty. Limited
Published on 10/01/2026 at 10:15, 49 minutes ago OLB Completes Previously Announced Management Board Appointments
Published on 10/01/2026 at 10:12, 52 minutes ago DN Group AG strengthens senior management with sustainability expert Antje Biber
Published on 10/01/2026 at 10:05, 59 minutes ago Ensera launches alliance network with SHL Medical, Stevanato Group, Ypsomed, Argonaut and American Injectables
Published on 10/01/2026 at 10:46, 18 minutes ago Déclaration des transactions sur actions propres réalisées du 21/09/2026 au 25/09/2026
Published on 10/01/2026 at 10:46, 18 minutes ago Statement of transactions in own shares from September 21, 2026 to September 25, 2026
Published on 10/01/2026 at 09:54, 1 hour 10 minutes ago Septembre 2026 - Déclaration sur le nombre d'actions composant le capital social et sur le nombre de droits de vote correspondant
Published on 10/01/2026 at 08:30, 2 hours 35 minutes ago Eurazeo opens an office in Abu Dhabi, reinforcing its commitment to the Middle East
Published on 10/01/2026 at 08:30, 2 hours 35 minutes ago Cegedim Business Services dévoile Hospi-DM, sa nouvelle offre SaaS de traçabilité des dispositifs médicaux, lors des 36èmes Journées Euro-Pharmat
